98 related articles for article (PubMed ID: 18844063)
1. [Clinical features of pure erythroid leukemia--case report and review of literature].
Zhang YM; Wu DP; Sun YM; Lu SH; Zhu MQ
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):293-5. PubMed ID: 18844063
[TBL] [Abstract][Full Text] [Related]
2. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
3. Essential thrombocythemia terminating in pure erythroleukemia.
Kreft A; Burg J; Fischer T; Kirkpatrick CJ
Am J Hematol; 2004 Oct; 77(2):140-3. PubMed ID: 15389906
[TBL] [Abstract][Full Text] [Related]
4. Acute rhabdomyolysis as a complication of cytarabine chemotherapy for acute myeloid leukemia: case report and review of literature.
Truica CI; Frankel SR
Am J Hematol; 2002 Aug; 70(4):320-3. PubMed ID: 12210815
[TBL] [Abstract][Full Text] [Related]
5. [Picture in clinical hematology no. 38: pure erythroid leukemia].
Nakamura K; Dan K
Rinsho Ketsueki; 2009 Jun; 50(6):445. PubMed ID: 19571502
[No Abstract] [Full Text] [Related]
6. Congenital immature pure erythroid leukemia with E-cadherin expression.
Tamura A; Uemura S; Saito A; Okubo S; Nino N; Tahara T; Yokoi T; Kishimoto K; Ishida T; Hasegawa D; Kawasaki K; Yoshimoto S; Nakao H; Yoshida M; Kosaka Y
Int J Hematol; 2017 Nov; 106(5):711-717. PubMed ID: 28523571
[TBL] [Abstract][Full Text] [Related]
7. KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation.
McClintock-Treep SA; Horny HP; Sotlar K; Foucar MK; Reichard KK
J Clin Pathol; 2009 Dec; 62(12):1147-9. PubMed ID: 19729359
[TBL] [Abstract][Full Text] [Related]
8. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
10. Effects of multidrug resistance gene expression in acute erythroleukemia.
Mazzella FM; Kowal-Vern A; Shrit MA; Rector JT; Cotelingam JD; Schumacher HR
Mod Pathol; 2000 Apr; 13(4):407-13. PubMed ID: 10786807
[TBL] [Abstract][Full Text] [Related]
11. Early expression of glycophorin C during normal and leukemic human erythroid differentiation.
Villeval JL; Le Van Kim C; Bettaieb A; Debili N; Colin Y; el Maliki B; Blanchard D; Vainchenker W; Cartron JP
Cancer Res; 1989 May; 49(10):2626-32. PubMed ID: 2469535
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukaemia (M6B: pure acute erythroid leukaemia) in a Thoroughbred foal.
Forbes G; Feary DJ; Savage CJ; Nath L; Church S; Lording P
Aust Vet J; 2011 Jul; 89(7):269-72. PubMed ID: 21696377
[TBL] [Abstract][Full Text] [Related]
13. [Cytological features and prognosis of megakaryoblastic leukemia].
Miyoshi Y; Takahashi N; Tada J; Higuchi T; Maeda T; Shimizu T; Harada H; Okada S; Mori H; Niikura H
Rinsho Ketsueki; 1994 Jun; 35(6):541-6. PubMed ID: 8078188
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a new erythroblastic leukemia cell line, EEB: phosphatidylglucoside-mediated erythroid differentiation and apoptosis.
Kawano-Yamamoto C; Muroi K; Nagatsuka Y; Higuchi M; Kikuchi S; Nagai T; Hakomori SI; Ozawa K
Leuk Res; 2006 Jul; 30(7):829-39. PubMed ID: 16332389
[TBL] [Abstract][Full Text] [Related]
15. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
16. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
17. [Acute erythroblastic leukemia presenting as FAB M6 with surface marker positive for megakaryocytic and erythroid: report of a case].
Ohata M; Sugiura K; Otsuka S; Nonaka K; Nakazawa M
Rinsho Ketsueki; 1994 Feb; 35(2):127-34. PubMed ID: 8139110
[TBL] [Abstract][Full Text] [Related]
18. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
19. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kiełbiński M; Zawilska K; Kłoczko J; Wrzesień-Kuś A;
Eur J Haematol; 2008 Feb; 80(2):115-26. PubMed ID: 18076637
[TBL] [Abstract][Full Text] [Related]
20. Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.
Wang HY; Huang LJ; Liu Z; Garcia R; Li S; Galliani CA
Hum Pathol; 2011 May; 42(5):749-58. PubMed ID: 21237494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
